Akari Therapeutics (AKTX)
0.90
-0.04 (-3.95%)
At close: Mar 04, 2025, 11:48 AM
Akari Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -10.01M | -17.75M | -17.42M | -20.45M | -24.75M | -23.5M | -35.4M | -18.14M | -45.32M | -9.65M | -3.62M | -4.27M | -2.12M | -675K |
| Depreciation & Amortization | 4K | 3.71K | 4.13K | 8K | 18K | 39K | 42.4K | 39.94K | 10.16K | 8K | 2K | 2K | n/a | n/a |
| Stock-Based Compensation | 1.15M | 735K | 314.65K | 325.52K | 1.05M | 1.65M | 2.73M | 3.93M | 1.79M | 468K | 94K | 514K | 140K | n/a |
| Other Working Capital | 70K | -877.11K | -1.74M | -2.91M | 5.89M | 3.07M | 799.05K | -778.59K | -3.75B | 33K | -434K | 1.4M | 475K | 181K |
| Other Non-Cash Items | -7.65M | -5.32M | 242.5K | 3.22M | 169K | -105K | 2.7M | -9.01M | 45.29M | -552K | -286K | -418K | -120K | -95K |
| Deferred Income Tax | n/a | n/a | n/a | 2.86M | 2.99M | n/a | -2.49M | -3 | -11.41M | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 70K | 821.89K | -1.98M | -2.91M | 8.27M | -619K | 811.27K | -1.45M | 4.67M | 263K | -1.64M | 2.04M | 1.09M | 404K |
| Operating Cash Flow | -16.43M | -21.5M | -18.85M | -16.95M | -12.26M | -22.54M | -31.6M | -24.62M | -4.97M | -9.46M | -5.45M | -2.13M | -1.01M | -366K |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -36.88K | -54.75K | -10.56K | -57K | n/a | 4K | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.41M | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -46.12M | n/a | -142K | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 10.02M | 36.1M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 10.02K | 10.08K | -8.22K | -142K | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 9.99M | -10.07M | 1.39M | -199K | n/a | 4K | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 432.35K | -1.1M | 890K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 7.02M | 94K | n/a | 27.5K | n/a | -194K | n/a | n/a | -5.96M | 4.1M | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 7.02M | 25.29M | 14.29M | 25.07M | 11.99M | 306K | 15.67M | n/a | 69.04M | 8.22M | 12M | 3.23M | 1M | 372K |
| Net Cash Flow | -9.4M | 3.89M | -4.69M | 8.32M | -236K | -22.28M | -5.99M | -34.82M | 65.59M | -1.44M | 6.55M | 1.1M | -3K | 6K |
| Free Cash Flow | -16.43M | -21.5M | -18.85M | -16.95M | -12.26M | -22.54M | -31.64M | -24.68M | -4.98M | -9.52M | -5.45M | -2.13M | -1.01M | -366K |